Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01528020
Other study ID # 41565-C
Secondary ID R01MH090159-01A1
Status Completed
Phase N/A
First received February 2, 2012
Last updated May 16, 2016
Start date January 2012
Est. completion date May 2016

Study information

Verified date May 2016
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Suicide is the third leading cause of death among adolescents in the US yet there is a paucity of research on effective treatments for this population. The primary aim of the research described in this application is to evaluate the efficacy of dialectical behavior therapy (DBT) for suicidal adolescents. DBT has an empirical track record with suicidal adults of reducing the incidence, frequency and medical risk of suicide attempts and non-suicidal self-injuries among individuals meeting criteria for borderline personality disorder (BPD). While DBT is widely used in the community with suicidal adolescents, particularly those with difficulties characteristic of BPD such as poor emotion regulation and impulse control, no randomized trial of DBT with suicidal adolescents has ever been conducted. And, while non-randomized trials indicate that the intervention is both safe and effective, without a randomized trial the investigators simply do not know whether DBT for suicidal adolescents is efficacious or not. Given the severity of the problem and the lack of alternative treatments for high risk adolescents, addressing this question is of great importance. The second aim of the research is to analyze mediators of reduced suicidal and self-injurious behaviors in adolescents. 170 adolescents at two sites (Seattle and Los Angeles) will be randomized to DBT or Individual and Supportive Group Therapy (IGST). Both treatments include 6 months of individual and group treatment and adolescents and a parent complete 5 assessments over a 1-year period.


Recruitment information / eligibility

Status Completed
Enrollment 173
Est. completion date May 2016
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Both
Age group 13 Years to 17 Years
Eligibility Inclusion Criteria:

1. Current suicide ideation;

2. More than one intentional self-injury or suicide attempt;

3. Has difficulties with emotion and impulsive behavior or has characteristics similar to borderline personality disorder;

4. 13-17 years of age;

5. At least one family member or responsible adult available to participate in assessments and treatment.

Exclusion Criteria:

- Has significant developmental delays

- Has significant current mania, psychosis or life threatening anorexia

- Has a court order for treatment

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Dialectical Behavior Therapy
DBT is a cognitive behavioral approach to treatment that synthesizes change based strategies characteristic of behavior therapy and validation strategies consistent with acceptance based treatments through application of dialectical principles and techniques. Based on a combined capability deficit and motivational model which states that 1) adolescents with suicidal behaviors and borderline features lack important interpersonal, self-regulation and distress tolerance skills, and 2) personal and environmental factors often both block and/or inhibit use of behavioral skills that adolescents do have, and at times reinforce dysfunctional behaviors. The primary adaptation for adolescents is the inclusion of family in the DBT skills training portion of therapy as well as a much greater inclusion of parents in the management of high suicide risk.
Individual and Group Supportive Therapy
The aim of IGST is relief or reduction of symptoms, the promotion of personal growth including enhancement of adolescents' strengths/coping skills and capacity to use environmental supports and to help suicidal adolescents increase their sense of self-esteem. Treatment aims to reduce suicidal behavior and emotion dysregulation by helping the adolescent learn to trust and validate themselves. The overarching assumption in IGST is that adolescents become suicidal for a variety of reasons, but they often report feeling isolated, misunderstood, unloved and unwanted. IGST Interventions include providing a strong therapeutic alliance where the therapist provides an environment that is completely trusting and validating to counter the experience of the depressed/suicidal youth.

Locations

Country Name City State
United States Seattle Children's Hospital Seattle Washington

Sponsors (4)

Lead Sponsor Collaborator
University of Washington National Institute of Mental Health (NIMH), Seattle Children's Hospital, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Suicide Events 1 year Yes
See also
  Status Clinical Trial Phase
Completed NCT01502319 - Military Suicide Research Consortium N/A
Completed NCT01342809 - Follow up by General Practitioner After Self-poisoning N/A
Completed NCT01826240 - Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior Phase 1

External Links